Enveric Biosciences (ENVB) Net Margin Growth (3y) (2017 - 2020)
Enveric Biosciences (ENVB) Net Margin Growth (3y) (2017 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | -5,319.00 |
| 10 | Enveric Biosciences | 5.62 Mn | -2.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 2,417.00 |
| Jun 30, 2020 | 1,048.00 |
| Mar 31, 2020 | -981.00 |
| Dec 31, 2019 | -3,963.00 |
| Sep 30, 2019 | 1,696.00 |
| Jun 30, 2019 | 571.00 |
| Mar 31, 2019 | -275.00 |
| Dec 31, 2018 | -17,012.00 |
| Sep 30, 2018 | 4,230.00 |
| Jun 30, 2018 | -1,232.00 |
| Mar 31, 2018 | -4,437.00 |
| Jun 30, 2017 | -3,086.00 |